30 minutes

Hospital doctors

Preventing medication-related osteonecrosis of the jaw

Osteonecrosis of the jaw is a severe adverse effect reported with certain drugs commonly used in the treatment of cancers and osteoporosis. Although rare, it can severely impair quality of life. With greater life expectancy and more people living with cancer as a chronic disease, the pool of those “at risk” is increasing. Read the article on this subject then take the multiple choice assessment.

Learning outcomes

Upon completion of this module you should know:

  • How to take a history from and examine patients with osteonecrosis of the jaw
  • What drugs can cause this condition
  • How to manage affected patients.

Written by:

Lara Zebic, Vinod Patel


Assessment questions were written by BMJ clinical editors.

Last updated

08 May 2019

Release date

08 May 2019


Accreditor credit Accreditation statement
BMJ Learning 0.5 credits, 0:30 hours BMJ Learning has assigned half an hour of credit to the module and related journal article
BMJ Learning 1 credit, 1:00 hour BMJ Learning has assigned one hour of credit to this module
Preventing medication-related osteonecrosis of the jaw Rated 5/5 based on 13 customer reviews